Report Overview

The global cholesterol drugs market size stood at USD 3.96 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Global cholesterol market is expected to grow at brisk rate during the forecast period owing reasons like surge in risk of cardiovascular diseases & obesity, surge in aging population and rising awareness and adoption of preventive healthcare. Additionally, increase in healthcare expenditure by various governments around the world is also driving the cholesterol testing market. Furthermore, rapid technological advancements in cholesterol testing and growing focus on developing new products are the key factors contributing to the constant growth of technological advancements in cholesterol testing market globally. Growing health concerns among the population is creating huge demand for cholesterol testing. Moreover, government is also trying to improve the quality of testing and thus, the cholesterol testing market is anticipated to hold a huge growth potential for the market players in the coming years.



Market Drivers

Obese and geriatric population is at high risk of elevated cholesterol levels, as the concentration of cholesterol in plasma increase with age, which is expected to fuel growth of the cholesterol testing services market. Increasing awareness among population regarding regular health check-up in both developed and emerging economies has also expected to fuel growth of the global cholesterol testing services market. Moreover, increasing consumption of alcohol and factors such as physical inactivity, could lead to risk of high cholesterol levels. Furthermore, increasing smoking could lead to high cholesterol level, which is expected to increase demand for its diagnosis and drive cholesterol testing services market growth.